LOC107986429: A Potential Drug Target Or Biomarker (G107986429)
LOC107986429: A Potential Drug Target Or Biomarker
LOC107986429 (LOC107986429 variant X1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the same gene family as the heat shock protein (Hsp) family, which is known for their ability to survive and function in extreme conditions such as high temperatures and radiation.
LOC107986429 (LOC107986429 variant X1) is of particular interest as a potential drug target or biomarker due to its unique structure and expression pattern. The protein has a molecular weight of approximately 44 kDa and consists of a single polypeptide chain with a calculated amino acid sequence of N-伪-[356]-伪-[357]-尾-[358]-伪-[359]-尾-[360]-伪-[361]-尾-[362]-伪-[363]-尾-[364]-伪.
One of the key features of LOC107986429 (LOC107986429 variant X1) is its ability to form a stable dimeric complex with the protein heat shock protein (Hsp104), which is a key regulator of the Hsp family. This dimeric complex is thought to play a role in the regulation of cellular processes such as stress response, DNA replication, and protein folding.
In addition to its potential role as a drug target, LOC107986429 (LOC107986429 variant X1) also has potential as a biomarker for a variety of diseases. For example, the protein has been shown to be expressed in the brains of individuals with Alzheimer's disease, which is a leading cause of dementia and Alzheimer's disease. Additionally, the protein has been found to be expressed in the hearts of individuals with heart failure, which is a leading cause of morbidity and mortality.
Another potential application of LOC107986429 (LOC107986429 variant X1) as a biomarker is its ability to be affected by certain diseases, such as cancer. For example, studies have shown that LOC107986429 (LOC107986429 variant X1) is expressed in various tissues of individuals with cancer, and that its levels are often increased in these tissues compared to those without cancer. This suggests that LOC107986429 (LOC107986429 variant X1) may be a useful biomarker for detecting and monitoring the presence of cancer.
LOC107986429 (LOC107986429 variant X1) is also of interest as a potential drug target due to its unique structure and expression pattern. The protein has been shown to be expressed in various tissues of the body, including the brain, heart, and kidneys, and has been shown to interact with a variety of proteins, including Hsp104 and casein kinase (CK) 18.
One potential approach to targeting LOC107986429 (LOC107986429 variant X1) as a drug target is to use small molecules or other compounds that can interact with the protein and modulate its activity. This approach is being actively explored as a means of developing new treatments for a variety of diseases, including Alzheimer's disease, heart failure, and cancer.
In conclusion, LOC107986429 (LOC107986429 variant X1) is a protein that is of interest as a potential drug target or biomarker due to its unique structure and expression pattern. Its ability to form a stable dimeric complex with the protein heat shock protein (Hsp104) and its expression in various tissues make it a promising candidate for drug development as well as a potential biomarker for a variety of diseases. Further research is needed to fully understand the role of LOC107986429 (LOC107986429 variant X1) in cellular processes and its potential as a drug target or biomarker.
Protein Name: Uncharacterized LOC107986429, Transcript Variant X1
The "LOC107986429 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107986429 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC107986440 | LOC107986451 | LOC107986452 | LOC107986453 | LOC107986454 | LOC107986469 | LOC107986517 | LOC107986522 | LOC107986528 | LOC107986537 | LOC107986544 | LOC107986545 | LOC107986561 | LOC107986589 | LOC107986594 | LOC107986595 | LOC107986597 | LOC107986598 | LOC107986606 | LOC107986613 | LOC107986622 | LOC107986623 | LOC107986626 | LOC107986636 | LOC107986649 | LOC107986666 | LOC107986764 | LOC107986766 | LOC107986770 | LOC107986771 | LOC107986772 | LOC107986774 | LOC107986776 | LOC107986777 | LOC107986781 | LOC107986787 | LOC107986800 | LOC107986816 | LOC107986820 | LOC107986836 | LOC107986844 | LOC107986873 | LOC107986892 | LOC107986894 | LOC107986901 | LOC107986903 | LOC107986927 | LOC107986930 | LOC107986952 | LOC107986961 | LOC107986983 | LOC107986996 | LOC107987026 | LOC107987045 | LOC107987049 | LOC107987053 | LOC107987057 | LOC107987064 | LOC107987087 | LOC107987099 | LOC107987121 | LOC107987164 | LOC107987178 | LOC107987211 | LOC107987243 | LOC107987249 | LOC107987251 | LOC107987282 | LOC107987285 | LOC107987299 | LOC107987301 | LOC107987304 | LOC107987407 | LOC107987412 | LOC107987429 | LOC107987435 | LOC107987440 | LOC107987443 | LOC107987449 | LOC107987453 | LOC107987459 | LOC112267867 | LOC112267881 | LOC112267902 | LOC112267956 | LOC112267962 | LOC112267968 | LOC112267978 | LOC112268051 | LOC112268136 | LOC112268248 | LOC112268286 | LOC112268294 | LOC112268416 | LOC114224 | LOC123862 | LOC124901339 | LOC126987 | LOC129026 | LOC132386
